3rd Quarter - Report

DEFINIUM THERAPEUTICS (FKA MIND MEDICINE (MINDMED) INC.) for DEFINIUM THERAPEUTICS (FKA MIND MEDICINE (MINDMED) INC.)

Firm
Client
Income
—
Expenses
$130,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Lack of innovation in mental health. Need for more efficient communication/collaboration between FDA/DEA and need for VA to operationalize itself for when new therapies are approved by the FDA and rescheduled by the DEA.

LobbyistCovered position, as disclosed
JULIE GARNER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.